Press Releases
Genome Canada, Ontario Institute for Cancer Research and Thermo Fisher Scientific to focus on pancreatic, prostate and breast cancer CARLSBAD, Calif., July 30, 2019 /PRNewswire/ -- Genome Canada, the Ontario Institute for Cancer Research (OICR) and Thermo Fisher Scientific are collaboratin
Read more...30 July 2019
BURLINGTON, ON, July 30, 2019 /PRNewswire/ - Rapid Dose Therapeutics Corp. ("RDT") (CSE: DOSE) today report
Read more...30 July 2019
SOUTH SAN FRANCISCO, July 30, 2019 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its second quarter 2019 financial results after market close on Tuesday, August 6, 2019. Rigel senior management will follow the announcement with a live conference call and webcast at
Read more...DUBLIN and CAMBRIDGE, Mass., July 30, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) and
Read more...CARLSBAD, Calif., July 30, 2019 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on Wednesday, August 7th at 11:30 a.m. Eastern Time to discuss its second quarter 2019 financial results and report on pipeline and business progress.
Read more...MONMOUTH JUNCTION, N.J., July 30, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ:CTSO), a critical care immunotherapy leader commercializing its
Read more...30 July 2019
LITTLE FALLS, N.J. and CHICAGO, July 30, 2019 /PRNewswire/ -- Cantel Medical Corp. (NYSE:CMD) ("Cantel" or the "Company"), a global leader in instrument reprocessing and innovative infection prevention products and services, today announced that it has entered into a definitive agreement to acquire privately-held Hu-Friedy Mfg. Co. ("Hu-
Read more...TORONTO, July 30, 2019 /PRNewswire/ -- Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB: ASPCF) today announced that it will be taking an expanded role in the commercialization of NATESTO® in the U.S. The company has entered into an amended and restated licensing agreement with Aytu BioScience, Inc. (NASDAQ: AYTU), which will, upon closing, move th
Read more...Welsh, Carson, Anderson & Stowe Raises $4.3 Billion in Oversubscribed Thirteenth Private Equity Fund
30 July 2019
NEW YORK, July 30, 2019 /PRNewswire/ -- Welsh, Carson, Anderson & Stowe ("WCAS"), a leading private equity firm focused exclusively on the healthcare and technology industries, announced today that it has completed fundraising for WCAS XIII, L.P. ("WCAS XIII" or the "Fund"). The Fund, which was oversubscribed, closed at its hard cap of $4.3 bi
Read more...